Drug concentration heterogeneity facilitates the evolution of drug resistance
From MaRDI portal
Publication:4230628
DOI10.1073/pnas.95.20.11514zbMath0919.92023OpenAlexW2051205639WikidataQ36312295 ScholiaQ36312295MaRDI QIDQ4230628
Alan S. Perelson, Thomas B. Kepler
Publication date: 8 February 1999
Published in: Proceedings of the National Academy of Sciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1073/pnas.95.20.11514
chemotherapyevolution of resistancedrug concentrationsdynamics of virus productionproduction and selection of mutants
Related Items
Mathematical analysis of delay differential equation models of HIV-1 infection ⋮ The amplitudes of viral blips in HIV-1 infected patients treated with antiretroviral therapy are power-law distributed ⋮ A mathematical model for HIV treatment with time-varying antiretroviral therapy ⋮ Global dynamics of a two-strain HIV infection model with intracellular delay ⋮ Stochastic investigation of HIV infection and the emergence of drug resistance ⋮ Analysis of a fractional model for HIV CD\(4^+\) T-cells with treatment under generalized Caputo fractional derivative ⋮ Modeling HIV persistence, the latent reservoir, and viral blips ⋮ Global dynamics of a delay virus model with recruitment and saturation effects of immune responses ⋮ Stochastic modelling of viral blips in HIV-1-infected patients: effects of inhomogeneous density fluctuations ⋮ Stochastic modelling of the eradication of the HIV-1 infection by stimulation of latently infected cells in patients under highly active anti-retroviral therapy ⋮ Dynamics of an HIV-1 therapy model of fighting a virus with another virus ⋮ A general framework for multi-compartmental analysis of drug chemotherapy dynamics in human immunodeficiency virus type-1 infected individuals ⋮ Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV ⋮ The role of backward mutations on the within-host dynamics of HIV-1 ⋮ Modelling the dynamics of LCMV infection in mice. II: Compartmental structure and immunopathology ⋮ Comparison of three kinetic models of HIV-1 infection: implications for optimization of treatment ⋮ An in-depth analysis of the HIV-1/AIDS dynamics by comprehensive mathematical modeling ⋮ Optimizing within-host viral fitness: infected cell lifespan and virion production rate ⋮ Linking within- and between-host scales for understanding the evolutionary dynamics of quantitative antimicrobial resistance ⋮ Modeling antiretrovial treatment to mitigate HIV in the brain: impact of the blood-brain barrier ⋮ Emergence of HIV-1 drug resistance during antiretroviral treatment ⋮ Time-adaptive determination of drug efficacy in mathematical model of HIV infection ⋮ Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity ⋮ Counterintuitive properties of evolutionary measures: a stochastic process study in cyclic population structures with periodic environments ⋮ Ongoing HIV replication in lymph node sanctuary sites in treated individuals contributes to the total latent HIV at a very slow rate ⋮ Bio-inspired computational heuristics to study models of HIV infection of CD4+ T-cell ⋮ Investigation of fractal-fractional HIV infection by evaluating the drug therapy effect in the Atangana-Baleanu sense ⋮ Mathematical Modeling of HIV-1 Infection and Drug Therapy ⋮ Role of \(CD4^{+}\) T-cell proliferation in HIV infection under antiretroviral therapy ⋮ Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects ⋮ Stability analysis and numerical simulations of spatiotemporal HIV CD4+ T cell model with drug therapy ⋮ Modeling the role of altruism of antibiotic-resistant bacteria ⋮ Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility ⋮ Complete classification of global dynamics of a virus model with immune responses ⋮ Global stability and backward bifurcation of a general viral infection model with virus-driven proliferation of target cells ⋮ Permanence and extinction of a non-autonomous HIV-1 model with time delays ⋮ The logistic growth model as an approximating model for viral load measurements of influenza a virus ⋮ Reservoir interactions and disease emergence ⋮ Impact of latently infected cells on strain archiving within HIV hosts ⋮ Within-host viral dynamics in a multi-compartmental environment ⋮ Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor ⋮ Modeling interleukin-2-based immunotherapy in AIDS pathogenesis ⋮ The effect of spatiotemporal antibiotic inhomogeneities on the evolution of resistance ⋮ A diffusive virus model with a fixed intracellular delay and combined drug treatments ⋮ Global stability of a discrete virus dynamics model with Holling type-II infection function ⋮ Stability analysis of delay differential equation models of HIV-1 therapy for fighting a virus with another virus ⋮ Spatial Aspects of HIV Infection ⋮ Viral infection in internally structured hosts. I: Conditions for persistent infection ⋮ Production of resistant HIV mutants during antiretroviral therapy ⋮ STABILITY ANALYSIS AND OPTIMAL CONTROL OF AN INTRACELLULAR HIV INFECTION MODEL WITH ANTIRETROVIRAL TREATMENT ⋮ Global analysis of a multi-group viral infection model with age structure ⋮ Global stability analysis of HIV-1 infection model with three time delays ⋮ DYNAMICAL MODEL OF IN-HOST HIV INFECTION: WITH DRUG THERAPY AND MULTI VIRAL STRAINS
